EP4486923A4 - Verfahren für multimodale epigenetische sequenzierungstests - Google Patents
Verfahren für multimodale epigenetische sequenzierungstestsInfo
- Publication number
- EP4486923A4 EP4486923A4 EP23764100.6A EP23764100A EP4486923A4 EP 4486923 A4 EP4486923 A4 EP 4486923A4 EP 23764100 A EP23764100 A EP 23764100A EP 4486923 A4 EP4486923 A4 EP 4486923A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- sequalization
- epigenetic
- multimodal
- tests
- procedures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Epidemiology (AREA)
- Bioethics (AREA)
- Software Systems (AREA)
- Public Health (AREA)
- Databases & Information Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263316277P | 2022-03-03 | 2022-03-03 | |
| PCT/US2023/063522 WO2023168297A2 (en) | 2022-03-03 | 2023-03-01 | Methods for multimodal epigenetic sequencing assays |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4486923A2 EP4486923A2 (de) | 2025-01-08 |
| EP4486923A4 true EP4486923A4 (de) | 2026-03-11 |
Family
ID=87884349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP23764100.6A Pending EP4486923A4 (de) | 2022-03-03 | 2023-03-01 | Verfahren für multimodale epigenetische sequenzierungstests |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230323473A1 (de) |
| EP (1) | EP4486923A4 (de) |
| JP (1) | JP2025508977A (de) |
| CN (1) | CN118922563A (de) |
| AU (1) | AU2023228901A1 (de) |
| WO (1) | WO2023168297A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025251032A1 (en) * | 2024-05-31 | 2025-12-04 | Helio Health Inc. | Liver cancer methylation markers and machine models |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190352695A1 (en) * | 2018-01-10 | 2019-11-21 | Guardant Health, Inc. | Methods for fragmentome profiling of cell-free nucleic acids |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190287645A1 (en) * | 2016-07-06 | 2019-09-19 | Guardant Health, Inc. | Methods for fragmentome profiling of cell-free nucleic acids |
| US20220251640A1 (en) * | 2019-05-17 | 2022-08-11 | The Broad Institute, Inc. | Methods of determination of genome architecture and epigenetic profile |
| AU2020283042B2 (en) * | 2019-05-31 | 2026-02-19 | Freenome Holdings, Inc. | Methods and systems for high-depth sequencing of methylated nucleic acid |
| GB2612447B (en) * | 2020-04-24 | 2025-08-13 | Univ Cornell | Methods for detecting tissue damage, graft versus host disease, and infections using cell-free DNA profiling |
| WO2022147420A1 (en) * | 2020-12-30 | 2022-07-07 | Guardant Health, Inc. | Detection of epigenetic status using sequence-specific degradation |
-
2023
- 2023-03-01 JP JP2024552339A patent/JP2025508977A/ja active Pending
- 2023-03-01 CN CN202380030116.7A patent/CN118922563A/zh active Pending
- 2023-03-01 WO PCT/US2023/063522 patent/WO2023168297A2/en not_active Ceased
- 2023-03-01 AU AU2023228901A patent/AU2023228901A1/en active Pending
- 2023-03-01 EP EP23764100.6A patent/EP4486923A4/de active Pending
- 2023-03-01 US US18/116,196 patent/US20230323473A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190352695A1 (en) * | 2018-01-10 | 2019-11-21 | Guardant Health, Inc. | Methods for fragmentome profiling of cell-free nucleic acids |
Non-Patent Citations (3)
| Title |
|---|
| CRISTIANO STEPHEN ET AL: "Genome-wide cell-free DNA fragmentation in patients with cancer", NATURE,, vol. 570, no. 7761, 29 May 2019 (2019-05-29), pages 385 - 389, XP036814426, [retrieved on 20190529], DOI: 10.1038/S41586-019-1272-6 * |
| ERGER FLORIAN ET AL: "cfNOMe - A single assay for comprehensive epigenetic analyses of cell-free DNA", GENOME MEDICINE, vol. 12, no. 1, 24 June 2020 (2020-06-24), XP093354440, ISSN: 1756-994X, DOI: 10.1186/s13073-020-00750-5 * |
| SIEJKA-ZIELINSKA PAULINA ET AL: "Cell-free DNA TAPS provides multimodal information for early cancer detection", SCI. ADV, vol. 7, no. 36, 1 September 2021 (2021-09-01), XP055978148 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025508977A (ja) | 2025-04-10 |
| WO2023168297A3 (en) | 2023-11-30 |
| WO2023168297A2 (en) | 2023-09-07 |
| AU2023228901A1 (en) | 2024-09-12 |
| US20230323473A1 (en) | 2023-10-12 |
| EP4486923A2 (de) | 2025-01-08 |
| CN118922563A (zh) | 2024-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4093311C0 (de) | Verfahren für verbesserte elektronikunterstützte medizinische verfahren | |
| EP4088211C0 (de) | Verfahren für fernzugriff | |
| EP4320275A4 (de) | Verbesserte verfahren und zusammensetzungen für synthetische biomarker | |
| EP4046159C0 (de) | Verfahren für automatisierte chromosomenanalyse | |
| EP4150106A4 (de) | Verfahren für ligationsgekoppelte pcr | |
| EP4147272A4 (de) | Pad-out-struktur für xtacking-architektur | |
| EP4292364A4 (de) | Verfahren und vorrichtungen für erweiterte suchraumsatzgruppenumschaltungen | |
| EP4232584A4 (de) | Screening-plattform für adar-rekrutierende guide-rnas | |
| EP4396375A4 (de) | Zusammensetzungen, verfahren und systeme für nichtinvasive pränatale tests | |
| EP4121505A4 (de) | Reagenzträger für schnelle diagnostische tests | |
| EP4238780C0 (de) | Auflauffähiges prüffahrzeug | |
| EP4115566A4 (de) | System-in-loop-test für adas-socs | |
| EP4262831A4 (de) | Verfahren für zelltherapien | |
| EP4486923A4 (de) | Verfahren für multimodale epigenetische sequenzierungstests | |
| EP4154823A4 (de) | Subjektprobenwerkzeug für virustests | |
| EP4416300A4 (de) | Test für antibiotikaempfindlichkeit | |
| EP4463755A4 (de) | Verfahren und systeme für neurofeedback-training | |
| EP4441679A4 (de) | Verfahren für eingangsinventarausbau | |
| EP4403773A4 (de) | Testverfahren | |
| EP4388277A4 (de) | Kantentester für handwerkzeuge | |
| EP4140141A4 (de) | Zahlenbeschränkung für unterschichten | |
| EP4091239C0 (de) | Prüffahrzeug | |
| EP4487632A4 (de) | Verfahren für mehrere prach-übertragungen | |
| EP4482954A4 (de) | Verfahren für gezielte oligo-proximitätsligation | |
| EP4500873A4 (de) | Visuelle analysevorrichtung für begrenzte pfade |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20241002 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20260209 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12Q 1/6886 20180101AFI20260203BHEP Ipc: G16B 20/00 20190101ALI20260203BHEP Ipc: G16H 50/20 20180101ALI20260203BHEP Ipc: G16B 40/20 20190101ALI20260203BHEP |